CYTOKINETICS INC — Director's Dealing 2015

Mar 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2015-02-26

Reporting Person: Malik Fady Ibraham (SVP Research & Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-26	Incentive Stock Option (right to buy)	$7.96	A	11678	Acquired	2025-02-26	Common Stock (11678)	Direct
2015-02-26	Non-Qualified Stock Option (right to buy)	$7.96	A	88322	Acquired	2025-02-26	Common Stock (88322)	Direct

Footnotes

F1: When the ISO and NQ dated 02/26/2015 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 100,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/26/2019.